Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT01302080
EFFECTS OF LONG-TERM SERTRALINE TREATMENT for OCD
This study is completed in the United States. It is testing EFFECTS OF LONG-TERM SERTRALINE TREATMENT for OCD.
OCDDrugFrom 6 Years to 16 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: April 4, 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 941
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 6 Years to 16 Years
- Official registry ID
- NCT01302080
- Official title
- SPRITES: SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NON-INTERVENTIONAL, LONGITUDINAL, COHORT STUDY TO EVALUATE THE EFFECTS OF LONG-TERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01302080. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 44 sites
- Harmonex Neuroscience ResearchDothan, AlabamaSite status: Not listed — confirm with the team
- Sun Valley Research CenterImperial, CaliforniaSite status: Not listed — confirm with the team
- UCLA Semel instituteLos Angeles, CaliforniaSite status: Not listed — confirm with the team
- Institute of Living/Hartford HospitalHartford, ConnecticutSite status: Not listed — confirm with the team
- Comprehensive Psychiatric CareNorwich, ConnecticutSite status: Not listed — confirm with the team
- University of FloridaGainesville, FloridaSite status: Not listed — confirm with the team
- Nemours Children's Clinic, Dept. of Psychology and PsychiatryJacksonville, FloridaSite status: Not listed — confirm with the team
- Medical Research Group of Central FloridaOrange City, FloridaSite status: Not listed — confirm with the team
- Harmonex Neuroscience of PensacolaPensacola, FloridaSite status: Not listed — confirm with the team
- University of South Florida - Rothman CenterSt. Petersburg, FloridaSite status: Not listed — confirm with the team
- Georgia Regents University AugustaAugusta, GeorgiaSite status: Not listed — confirm with the team
- Institute for Behavioral Medicine, LLCSmyrna, GeorgiaSite status: Not listed — confirm with the team
- Family Behavioral HealthPlainfield, IllinoisSite status: Not listed — confirm with the team
- University of Kansas School of Medicine/Dept. of PsychiatryKansas City, KansasSite status: Not listed — confirm with the team
- Family Service and Guidance CenterTopeka, KansasSite status: Not listed — confirm with the team
- Kennedy Krieger InstituteBaltimore, MarylandSite status: Not listed — confirm with the team
- Neuroscientific InsightsRockville, MarylandSite status: Not listed — confirm with the team
- Massachusetts General HospitalBoston, MassachusettsSite status: Not listed — confirm with the team
- Debora A. LaMonica, MDSouth Yarmouth, MassachusettsSite status: Not listed — confirm with the team
- Baystate Medical Center, Child Behavioral Health ResearchSpringfield, MassachusettsSite status: Not listed — confirm with the team
- Mayo ClinicRochester, MinnesotaSite status: Not listed — confirm with the team
- Comprehensive Psychiatric AssociatesGladstone, MissouriSite status: Not listed — confirm with the team
- Saint John's ClinicSpringfield, MissouriSite status: Not listed — confirm with the team
- Jersey Shore University Medical Center/Meridian HealthNeptune City, New JerseySite status: Not listed — confirm with the team
- Children's Specialized HospitalToms River, New JerseySite status: Not listed — confirm with the team
- Finger Lakes Clinical ResearchRochester, New YorkSite status: Not listed — confirm with the team
- 3-C Family Services, P.A.Cary, North CarolinaSite status: Not listed — confirm with the team
- Duke University Medical Center, Division of Child & Adolescent PsychiatryDurham, North CarolinaSite status: Not listed — confirm with the team
- Scott George Crowder, M.D.Wilmington, North CarolinaSite status: Not listed — confirm with the team
- Family Center by the FallsChagrin Falls, OhioSite status: Not listed — confirm with the team
- University Of CincinnatiCincinnati, OhioSite status: Not listed — confirm with the team
- Cincinnati Childrens Hospital and Medical CenterCincinnati, OhioSite status: Not listed — confirm with the team
- Case Western Reserve University, Department of Psychiatry Child/AdolescentCleveland, OhioSite status: Not listed — confirm with the team
- Cutting Edge Research GroupOklahoma City, OklahomaSite status: Not listed — confirm with the team
- Child Guidance Resource CenterHavertown, PennsylvaniaSite status: Not listed — confirm with the team
- Tullahoma Pediatrics PLLCTullahoma, TennesseeSite status: Not listed — confirm with the team
- University of Texas Southwestern Medical Center at DallasDallas, TexasSite status: Not listed — confirm with the team
- Bay Pointe Behavioral Health Service, Inc.Friendswood, TexasSite status: Not listed — confirm with the team
- Midtown Psychiatry and TMS CenterHouston, TexasSite status: Not listed — confirm with the team
- Peter Ly MDHouston, TexasSite status: Not listed — confirm with the team
- Focus and Balance, LLCSan Antonio, TexasSite status: Not listed — confirm with the team
- University of Virginia Health SystemCharlottesville, VirginiaSite status: Not listed — confirm with the team
- Clinical Research Partners, LLCPetersburg, VirginiaSite status: Not listed — confirm with the team
- McLean Hospital - Harvard Medical SchoolMilwaukee, WisconsinSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with ocd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving sertraline, psychotherapy. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Who might this study be for?
This study may concern people with ocd; age range: From 6 Years to 16 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01674361
Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in people with OCD (OCD)
This study is completed in the United States and in Canada. It is testing bitopertin for OCD.
CompletedNCT04693351
Troriluzole for OCD
This study is completed in the United States, in Canada, in the United Kingdom, .... It is testing troriluzole for OCD.
CompletedNCT00405535
Adjunctive Glycine for OCD
This study is completed. It focuses on OCD and currently lists study information in the United States.